Product Information
FEXOFENADINE HCL 180 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.2407 per EA under NDC 00904671146. Its NADAC has been published 419 times since Aug 15, 2018.
FDA first approved this application on Apr 11, 2006.
Strength
180 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904671146
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076502FDA Approved
4/11/2006
On Market Since
4/27/2018
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE HCL 180 MG TABLET has been published 419 times since Aug 15, 2018, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2407 per EA |
|---|---|
| All-time high | $0.3739 (Sep 12, 2018) |
| All-time low | $0.2079 (Nov 20, 2024) |
| 52-week high | $0.2728 |
| 52-week low | $0.2378 |
| Median price | $0.2799 |
| Average price | $0.2832 |
| Largest weekly change | -24.0% (Nov 20, 2024) |
| Weeks tracked | 419 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEXOFENADINE HCL 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE HCL 180 MG TABLET, manufactured by Major Pharmaceuticals, is $0.2407 per EA (NDC 00904671146), effective Aug 19, 2026.
How has the price of FEXOFENADINE HCL 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE HCL 180 MG TABLET has declined 30.1%. It has been tracked across 419 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE HCL 180 MG TABLET?
Since Aug 15, 2018, the NADAC for FEXOFENADINE HCL 180 MG TABLET has ranged from a low of $0.2079 (Nov 20, 2024) to a high of $0.3739 (Sep 12, 2018), with a median of $0.2799 per EA.
Are there cheaper alternatives to FEXOFENADINE HCL 180 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLERGY RELIEF 180 MG TABLET, is $0.2378 per EA — about 1% below FEXOFENADINE HCL 180 MG TABLET.
Who manufactures FEXOFENADINE HCL 180 MG TABLET?
FEXOFENADINE HCL 180 MG TABLET (NDC 00904671146) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.